Adoptive immunotherapy i.e. development of specific anti-tumor reactivity (e.g., tumor-infiltrating lymphocyte therapy) per course of treatment

S2107
HCPCS Code

2023 HCPCS
Billable/Valid Code

S2107 is a valid 2023 HCPCS Code that could be used to indicate Adoptive immunotherapy i.e. development of specific anti-tumor reactivity (e.g., tumor-infiltrating lymphocyte therapy) per course of treatment for reimbursement purposes.

S2107 belongs to Other Medical Items or Services Type of Service and has been in effect since Apr 01, 2002.

Short description for S2107 HCPCS code:

Adoptive immunotherapy

HCPCS S2107

S2107 code information

HCPCS code:	S2107
Description:	ADOPTIVE IMMUNOTHERAPY I.E. DEVELOPMENT OF SPECIFIC ANTI-TUMOR REACTIVITY (E.G., TUMOR-INFILTRATING LYMPHOCYTE THERAPY) PER COURSE OF TREATMENT
Effective Date:	Apr 01, 2002
Added Date:	Apr 01, 2002
Termination Date:	HCPCS S2107 was terminated on Nov 30, -0001
Pricing indicator:	`00` - SERVICE NOT SEPARATELY PRICED BY PART B (E.G., SERVICES NOT COVERED, BUNDLED, USED BY PART A ONLY, ETC.) PHYSICIAN FEE SCHEDULE AND NON-PHYSICIAN PRACTITIONERS
Multi Pricing indicator:	`9` - NOT APPLICABLE AS HCPCS NOT PRICED SEPARATELY BY PART B (PRICING INDICATOR IS 00) OR VALUE IS NOT ESTABLISHED (PRICING INDICATOR IS ´99´)
Coverage code:	`I` - NOT VALID FOR MEDICARE (NO GRACE PERIOD)
BETOS code:	`Z2` - UNDEFINED CODES
Action code:	`N` - NO MAINTENANCE FOR THIS CODE
Type of Service:	`9` - OTHER MEDICAL ITEMS OR SERVICES
Anesthesia BUQ:	0